Your browser doesn't support javascript.
Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations.
Thepmankorn, Parisorn; Bach, John; Lasfar, Ahmed; Zhao, Xilin; Souayah, Sami; Chong, Zhao Zhong; Souayah, Nizar.
  • Thepmankorn P; Department of Neurology, Rutgers New Jersey Medical School, Newark, NJ, United States.
  • Bach J; Department of Physical Medicine and Rehab, Rutgers New Jersey Medical School, Newark, NJ, United States.
  • Lasfar A; Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, United States.
  • Zhao X; Department of Microbiology, Biochemistry, & Molecular Genetics, Public Health Research Institute Center, Rutgers New Jersey Medical School, Newark, NJ, United States; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, United States.
  • Souayah S; Department of Neurology, Rutgers New Jersey Medical School, Newark, NJ, United States.
  • Chong ZZ; Department of Neurology, Rutgers New Jersey Medical School, Newark, NJ, United States.
  • Souayah N; Department of Neurology, Rutgers New Jersey Medical School, Newark, NJ, United States. Electronic address: souayani@njms.rutgers.edu.
Cytokine ; 138: 155404, 2021 02.
Article in English | MEDLINE | ID: covidwho-996816
ABSTRACT
The new coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can trigger a hyperinflammatory state characterized by elevated cytokine levels known as hypercytokinemia or cytokine storm, observed most often in severe patients. Though COVID-19 is known to be a primarily respiratory disease, neurological complications affecting both the central and peripheral nervous systems have also been reported. This review discusses potential routes of SARS-CoV-2 neuroinvasion and pathogenesis, summarizes reported neurological sequelae of COVID-19, and examines how aberrant cytokine levels may precipitate these complications. Clarification of the pathogenic mechanisms of SARS-CoV-2 is needed to encourage prompt diagnosis and optimized care. In particular, identifying the presence of cytokine storm in patients with neurological COVID-19 manifestations will facilitate avenues for treatment. Future investigations into aberrant cytokine levels in COVID-19 patients with neurological symptoms as well as the efficacy of cytokine storm-targeting treatments will be critical in elucidating the pathogenic mechanisms and effective treatments of COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cerebrovascular Disorders / Cytokines / Cytokine Release Syndrome / COVID-19 / Nervous System Diseases Topics: Long Covid Limits: Humans Language: English Journal: Cytokine Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: J.cyto.2020.155404

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Cerebrovascular Disorders / Cytokines / Cytokine Release Syndrome / COVID-19 / Nervous System Diseases Topics: Long Covid Limits: Humans Language: English Journal: Cytokine Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: J.cyto.2020.155404